EFFECTIVENESS AND SAFETY OF RECOMBINANT HUMAN GRANULOCYTIC COLONY-STIMULATING FACTOR IN TREATMENT OF GRANULOCYTOPENIA DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
Abstract
Key words: children, treatment, granulocytopenia, filgrastim, juvenile rheumatoid arthritis.
(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(4):94-100)
About the Authors
E.I. AlexeevaRussian Federation
S.I. Valieva
Russian Federation
T.M. Bzarova
Russian Federation
E.L. Semikina
Russian Federation
K.B. Isaeva
Russian Federation
A.O. Lisitsyn
Russian Federation
R.V. Denisova
Russian Federation
E.G. Chistyakova
Russian Federation
T.V. Sleptsova
Russian Federation
E.V. Mitenko
Russian Federation
References
1. Cassidy J., Petty R., eds. Texbook of paediatric rheumatology, 5th Ed. Elsevier Saunders. 2005.
2. Алексеева Е.И., Литвицкий П.Ф. Ювенильный ревматоидный артрит. Этиология. Патогенез. Клиника. Алгоритмы диагностики и лечения. Руководство для врачей, преподавателей, научных сотрудников. Под редакцией Баранова А.А. М. 2007. С. 325–339.
3. Woo P., Southwood T.R., Prieur A.M. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. 2000; 43(8): 1849–1857.
4. Насонов Е.Л. Ритуксимаб в лечении ревматических болезней. Научно-практическая ревматология. 2008; 1 (Приложение): 3–10.
5. Smolen J.S., Betteridge N., Breedveld F.C. et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2007; 66: 143–150.
6. Finckh A., Ciurea A., Brulhart L. et al. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis Rheum. 2007; 56: 1417–1423.
7. Алексеева Е.И, Валиева С.И. Бзарова Т.М. и др. Эффективность и безопасность повторных курсов лечения ритуксимабом тяжелого рефрактерного ювенильного ревматоидного артрита. Вопросы современной педиатрии. 2010; 9(5): 14–45.
8. Иванова Л.Ф., Багирова Н.С., Дмитриева Н.В. Профилактика и лечение фебрильных нейтропений у детей с острыми лейкозами. Методические рекомендации. М.: РОНЦ им. Н.Н. Блохина РАМН. 2002.
9. American Society of Clinical Oncology recommendations for the use of hematopoietic colony–stimulating factors: evidence based clinical practice guidelines. J. Clin. Oncol. 1994; 12: 2471–2508.
10. Bodey G.P., Buckley M., Sathe Y.S., Freireich E.J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 1966; 64(2): 328–340.
11. Glauser M.P., Pizzo P.A. Management of infections in immunocompromised patients. NY: W.B. Saunders Comp. Ltd. 2000. 473 р.
12. Hughes W.T., Armstrong D., Bodey G.P. et al. http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bow%20EJ%22%5BAuthor%5D2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 2002; 34 (6): 730–751.
13. Finberg R.W., Talcott J.A. Fever and neutropenia. How to use a new treatment strategy. N. Eng. J. Med. 1999; 341: 362–363.
14. Pizzo P.A. Fever in immunosuppressed patients. N. Eng. J. Med. 1999; 341: 893–900.
15. Scevola D. La profilassi antibiotica nella practica chirurgica e medica. Micom. 1998. 128 р.
16. The textbook of febrile neutripenia. Rolston K.V.I., Rubienstein E.B. 2001. 341 р.
17. Viscoli C. The evolution of the empirical management of fever and neutropenia in cancer patients. J. Antimicrob. Chemother. 1998; 41 (Suppl. D): 65–80.
18. Wood MJ. Viral infections in neutropenia-current problems and chemotherapeutic control. J. Antimicrob. Chemother. 1998; 41(Suppl D): 81–93.
19. Масчан А.А., Фечина Л.Г., Хлебникова О.П. и др. Эффективность и безопасность применения отечественного биоаналога филграстима для лечения и профилактики нейтропений у детей. Вопросы современной педиатрии. 2010; 9 (1): 18–26.
Review
For citations:
Alexeeva E., Valieva S., Bzarova T., Semikina E., Isaeva K., Lisitsyn A., Denisova R., Chistyakova E., Sleptsova T., Mitenko E. EFFECTIVENESS AND SAFETY OF RECOMBINANT HUMAN GRANULOCYTIC COLONY-STIMULATING FACTOR IN TREATMENT OF GRANULOCYTOPENIA DEVELOPED DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS. Current Pediatrics. 2010;9(4):94-100.
Email this article 
